文献速递胸部技术与安全CTMRPET

肿瘤患者肺结节检测——呼吸触发周期性旋转重叠平行采集T2加权成像联合PET/CT-MR评估的价值

Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR.
PubMed 文献 · Eur J Radiol · 2017-11-16

这项前瞻性单中心研究纳入149例恶性肿瘤分期患者,采用PET/CT-MR三模态协议并加做呼吸门控T2-PROPELLER序列,评估肺结节检测。结果显示T2-P对FDG阳性结节(92.4%)和恶性结节(75.9%)检出率显著高于T1-Dixon序列,对>10mm结节检出率(92.2%)与CT无显著差异,但<10mm结节MR检出率低于CT。

要点

  • 呼吸门控T2-PROPELLER序列对FDG阳性结节检出率92.4%,对确认恶性结节检出率75.9%,均显著高于T1-Dixon序列。
  • 对>10mm肺结节,T2-P检出率92.2%,与CT无统计学差异。
  • MR序列对<10mm结节的检出率显著低于CT。

核心结论

  • 尽管T2-P总体检出率低于CT,但在所有评估类别中均高于屏气T1加权MR序列;T2-P对FDG阳性结节、>10mm结节及结节清晰度的评估与CT无统计学差异,在肿瘤患者全身PET/MR分期中,T2-P可完成大部分临床相关的肺结节评估。

研究设计与样本

  • 前瞻性单中心研究,纳入149例恶性肿瘤分期患者,采用PET/CT-MR三模态协议,包括PET/CT和3T-MR成像(3D双回波GRE脉冲序列Dixon及轴位呼吸门控T2加权PROPELLER序列),以CT为参考评估肺实质结节的存在、清晰度、大小和判读。

诊断标准与关键数值

  • T2-P对299个肺结节的总体检出率为60%,显著高于T1-Dixon的16.1-37.8%(p<0.01)。
  • T2-P对FDG阳性结节检出率92.4%,对确认恶性结节检出率75.9%,均显著高于T1-Dixon。
  • T2-P对>10mm结节检出率92.2%,与CT无显著差异(p>0.05);对<10mm结节检出率低于CT(p<0.01)。
  • 逐患者分析显示,T2-P与CT检出的结节在临床判读上无显著变化。

临床应用与阅片要点

  • 在肿瘤患者全身PET/MR分期中,呼吸门控T2-PROPELLER序列对FDG阳性结节、>10mm结节及结节清晰度的评估与CT无统计学差异,可完成大部分临床相关的肺结节评估;但<10mm结节MR检出率低于CT,需注意小结节的检出局限。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To prospectively evaluate the detection and conspicuity of pulmonary nodules in an oncological population, using a tri-modality PET/CT-MR protocol including a respiration-gated T2-PROPELLER sequence for possible integration into a simultaneous PET/MR protocol.

METHODS: 149 patients referred for staging of malignancy were prospectively enrolled in this single-center study. Imaging was performed on a tri-modality PET/CT-MR setup and was comprised of PET/CT and 3T-MR imaging with 3D dual-echo GRE pulse sequence (Dixon) and an axial respiration-gated T2-weighted PROPELLER (T2-P) sequence. Images were assessed for presence, conspicuity, size and interpretation of the pulmonary parenchymal nodules. McNemar's test was used to evaluate paired differences in nodule detection rates between MR and CT from PET/CT. The correlation of pulmonary nodule size in CT and MR imaging was assessed using Pearson correlation coefficient.

RESULTS: 299 pulmonary nodules were detected on PET/CT. The detectability was significantly higher on T2-P (60%, p<0.01) compared to T1-weighted Dixon-type sequences (16.1-37.8%). T2-P had a significantly higher detection rate among FDG-positive (92.4%) and among confirmed malignant nodules (75.9%) compared to T1-Dixon. Nodules <10mm were detected less often by MR sequences than by CT (p < 0.01). However, nodules >10mm were detected equally well with T2-P (92.2%) and CT (p >0.05). In a per-patient analysis, there was no significant change in the clinical interpretation of the nodules detected with T2-P and CT.

CONCLUSION: Despite the overall lower detection rate compared with CT, the free-breathing respiratory gating T2-w sequence showed higher detectability in all evaluated categories compared to breath-hold T1-weighted MR sequences. Specifically, the T2-P was found to be not statistically different from CT in FDG-positive nodules, in detection of nodules >10mm and concerning conspicuity of pulmonary nodules. Overall, the additional time investment into T2-P seems to be justified since clinical relevant assessment of pulmonary lung nodules can mostly be done by T2-P in a whole body PET/MR staging of oncologic patients.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. de Galiza Barbosa F, Geismar JH, Delso G, et al. Pulmonary nodule detection in oncological patients - Value of respiratory-triggered, periodically rotated overlapping parallel T2-weighted imaging evaluated with PET/CT-MR. Eur J Radiol. 2017. PMID: 29279157. doi:10.1016/j.ejrad.2017.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。